DETECT ALZHEIMERS

DETECT ALZHEIMERS

<< Back to CME Activities
Show : Per page of 84

Advancing Recognition, Intervention, and Assessment of ARIA to Optimize the Therapeutic Potential of Anti-Amyloid Therapies for Patients with Alzheimer’s Disease

Region: United States | Target Audience: Neurologists and Psychiatrists

This enduring activity brings together leading experts across multiple disciplines to advance practical knowledge in recognizing, monitoring, and managing amyloid-related imaging abnormalities (ARIA) in patients with Alzheimer’s disease receiving anti-amyloid therapies (AATs). Through case-based discussion, evidence-driven updates, and multidisciplinary perspectives, the program focuses on improving confidence in ARIA identification, optimizing collaborative workflows across care settings, and strengthening patient-centered communication and shared decision-making to support safe and effective treatment.

RELEASED DATE: March 19, 2026
EXPIRATION DATE: March 19, 2027

Learn More & View Event »

Advancing Recognition, Intervention, and Assessment of ARIA to Optimize the Therapeutic Potential of Anti-Amyloid Therapies for Patients with Alzheimer’s Disease

Region: Asia | Target Audience: Radiologists and Neuroradiologists

This enduring activity brings together leading experts across multiple disciplines to advance practical knowledge in recognizing, monitoring, and managing amyloid-related imaging abnormalities (ARIA) in patients with Alzheimer’s disease receiving anti-amyloid therapies (AATs). Through case-based discussion, evidence-driven updates, and multidisciplinary perspectives, the program focuses on improving confidence in ARIA identification, optimizing collaborative workflows across care settings, and strengthening patient-centered communication and shared decision-making to support safe and effective treatment.

RELEASED DATE: May 08, 2026
EXPIRATION DATE: May 08, 2027

Learn More & View Event »

Advancing Recognition, Intervention, and Assessment of ARIA to Optimize the Therapeutic Potential of Anti-Amyloid Therapies for Patients with Alzheimer’s Disease

Region: Europe | Target Audience: Radiologists and Neuroradiologists

This enduring activity brings together leading experts across multiple disciplines to advance practical knowledge in recognizing, monitoring, and managing amyloid-related imaging abnormalities (ARIA) in patients with Alzheimer’s disease receiving anti-amyloid therapies (AATs). Through case-based discussion, evidence-driven updates, and multidisciplinary perspectives, the program focuses on improving confidence in ARIA identification, optimizing collaborative workflows across care settings, and strengthening patient-centered communication and shared decision-making to support safe and effective treatment.

RELEASED DATE: May 08, 2026
EXPIRATION DATE: May 08, 2027

Learn More & View Event »

Advancing Recognition, Intervention, and Assessment of ARIA to Optimize the Therapeutic Potential of Anti-Amyloid Therapies for Patients with Alzheimer’s Disease

Region: United States | Target Audience: Radiologists and Neuroradiologists

This enduring activity brings together leading experts across multiple disciplines to advance practical knowledge in recognizing, monitoring, and managing amyloid-related imaging abnormalities (ARIA) in patients with Alzheimer’s disease receiving anti-amyloid therapies (AATs). Through case-based discussion, evidence-driven updates, and multidisciplinary perspectives, the program focuses on improving confidence in ARIA identification, optimizing collaborative workflows across care settings, and strengthening patient-centered communication and shared decision-making to support safe and effective treatment.

RELEASED DATE: May 08, 2026
EXPIRATION DATE: May 08, 2027

Learn More & View Event »

Advancing Recognition, Intervention, and Assessment of ARIA to Optimize the Therapeutic Potential of Anti-Amyloid Therapies for Patients with Alzheimer’s Disease

Region: Asia | Target Audience: Neurologists and Psychiatrists

This enduring activity brings together leading experts across multiple disciplines to advance practical knowledge in recognizing, monitoring, and managing amyloid-related imaging abnormalities (ARIA) in patients with Alzheimer’s disease receiving anti-amyloid therapies (AATs). Through case-based discussion, evidence-driven updates, and multidisciplinary perspectives, the program focuses on improving confidence in ARIA identification, optimizing collaborative workflows across care settings, and strengthening patient-centered communication and shared decision-making to support safe and effective treatment.

RELEASED DATE: March 19, 2026
EXPIRATION DATE: March 19, 2027

Learn More & View Event »

Advancing Recognition, Intervention, and Assessment of ARIA to Optimize the Therapeutic Potential of Anti-Amyloid Therapies for Patients with Alzheimer’s Disease

Region: Europe | Target Audience: Neurologist and Psychiatrists

This enduring activity brings together leading experts across multiple disciplines to advance practical knowledge in recognizing, monitoring, and managing amyloid-related imaging abnormalities (ARIA) in patients with Alzheimer’s disease receiving anti-amyloid therapies (AATs). Through case-based discussion, evidence-driven updates, and multidisciplinary perspectives, the program focuses on improving confidence in ARIA identification, optimizing collaborative workflows across care settings, and strengthening patient-centered communication and shared decision-making to support safe and effective treatment.

RELEASED DATE: March 19, 2026
EXPIRATION DATE: March 19, 2027

Learn More & View Event »

DETECT— Engaging Patients, Caregivers, and Multidisciplinary Providers in the Shared Goal of Facilitating an Earlier Alzheimer’s Disease Diagnosis and Optimizing the Use of Anti-Amyloid Therapies

Treatment Topic: Optimizing the Use of Anti-Amyloid Therapy for Early Asymptomatic AD

This case-based educational enduring activity is designed to help Alzheimer’s disease and dementia healthcare providers optimize the use of anti-amyloid therapy for early Alzheimer’s disease. Through interactive case-based learning, our faculty will assist learners in developing strategies to improve multidisciplinary and clinician/patient communication skills to facilitate the best possible treatment outcomes.

RELEASED DATE: August 29, 2025
EXPIRATION DATE: August 29, 2026

Learn More & View Event »

DETECT— Engaging Patients, Caregivers, and Multidisciplinary Providers in the Shared Goal of Facilitating an Earlier Alzheimer’s Disease Diagnosis and Optimizing the Use of Anti-Amyloid Therapies

Facilitating an Earlier Alzheimer’s Disease Diagnosis

This case-based educational activity is designed to help Alzheimer’s disease and dementia providers diagnose AD earlier in the disease course through comprehensive history and physical, validated cognitive assessments, neuroimaging, and referral, when appropriate. Through interactive case-based learning, our faculty will assist learners in developing strategies to improve multidisciplinary care and clinician/patient communication to facilitate the best possible treatment outcomes.

RELEASED DATE: August 29, 2025
EXPIRATION DATE: August 29, 2026

Learn More & View Event »

DETECT— Engaging Patients, Caregivers, and Multidisciplinary Providers in the Shared Goal of Facilitating an Earlier Alzheimer’s Disease Diagnosis and Optimizing the Use of Anti-Amyloid Therapies

Part 1: Facilitating Earlier Diagnosis of Alzheimer's Disease

This two-part case-based educational grand rounds activity is designed to enhance the capabilities of healthcare providers in managing Alzheimer’s disease and related dementias. Part one focuses on early diagnosis of AD through comprehensive history and physical examinations, quantitative assessments, neuroimaging, and appropriate referrals.

RELEASED DATE: October 31, 2025
EXPIRATION DATE: October 31, 2026

Learn More & View Event »

DETECT— Engaging Patients, Caregivers, and Multidisciplinary Providers in the Shared Goal of Facilitating an Earlier Alzheimer’s Disease Diagnosis and Optimizing the Use of Anti-Amyloid Therapies

Part 2: Optimizing the Use of Anti-Amyloid Therapy for Early Asymptomatic AD

This two-part case-based educational grand rounds activity is designed to enhance the capabilities of healthcare providers in managing Alzheimer’s disease and related dementias. Part two will equip learners with strategies to optimize the use of amyloid-targeting therapies and improve multidisciplinary collaboration and clinician-patient communication to achieve the best possible treatment outcomes.

RELEASED DATE: November 12, 2025
EXPIRATION DATE: November 12, 2026

Learn More & View Event »
Scroll to Top

Scientific Council

Marc Agronin, MD

Chief Medical Officer
Frank C. and Lynn Scaduto MIND Institute and Behavioral Health
Miami Jewish Health
Miami, FL

Liana G. Apostolova, MD, MSc, FAAN

Associate Dean of Alzheimer’s Disease Research
Indiana University Distinguished Professor
Barbara and Peer Baekgaard Professor of Alzheimer's Disease Research
Professor in Neurology, Radiology, Medical and Molecular Genetics
Indiana University School of Medicine
Department of Neurology
Indianapolis, IN

Alireza Atri, MD, PhD

Chief Medical Officer, Banner Research
Banner Alzheimer’s and Research Institutes
Pheonix, Sun City, and Tucson, AZ
Director, Banner Sun Health Research Institute
Sun City, AZ

Frederik Barkhof, MD, PhD, FRCR

Professor of Neuroradiology
Department of Radiology and Nuclear Medicine
Amsterdam UMC (location VU mc)
Amsterdam, The Netherlands
UCL Queen Square Institute of Neurology
UCL Hawkes Institute
London, United Kingdom

Sharon A. Brangman, MD, FACP, AGSF

Distinguished Service Professor
Chair, Department of Geriatrics
Director, Upstate Center of Excellence for Alzheimer’s Disease
SUNY Upstate Medical University
Syracuse, New York

Christopher Chen, BM BCh, MRCP, FAMS, FRCP

Professor, Department of Pharmacology
Director, Memory Aging and Cognition Centre
Yong Loo Lin School of Medicine
National University of Singapore
Singapore

Choong Chih Ching, MBChb NZ, FRCR UK

Senior Consultant, Department of Diagnostic Imaging
RadLink, Singapore
Visiting Consultant, National University Hospital and National Cancer Centre of Singapore

Anupama Roy Chowdhury, MBBS, MRCP, FAMS

Head and Senior Consultant
Department of Geriatric Medicine
Singapore General Hospital
Singapore

Natalie Christian, MD

Assistant Professor, Geriatrics
Program Director, Geriatric Medicine Fellowship
Tulane University School of Medicine
Southeast Louisiana Veterans Healthcare System
New Orleans, LA

Petrice M. Cogswell, MD, PhD

Associate Professor
Mayo Clinic
Rochester, Minnesota

Ariel F. Cole, MD, FAAFP

Program Director, AdventHealth Geriatric Fellowship
Winter Park, FL

Brad Dickerson, MD, MMSc, FAAN, FANPA

Professor of Neurology, Harvard Medical School
Director, Frontotemporal Disorders Unit, Department of Neurology, Massachusetts General Hospital
Boston, MA

Richard M. Dupee, MD, MACP, AGSF

Clinical Professor of Medicine
Tufts University School of Medicine
Clinical professor, Department of Public Health and Community Medicine, Tufts University
Chief, Geriatrics Service, Tufts Medical Center
Senior Physician, Pratt Diagnostic Center
Dean ex officio, Office of International Affairs, Tufts University School of Medicine
Boston, MA

Fanny Elahi, MD, PhD

Associate Professor of Neurology, Neuroscience, and AI and Human Health
Icahn School of Medicine
Mount Sinai
New York, NY

James M. Ellison, MD, MPH

Professor of Psychiatry and Human Behavior
Sidney Kimmel Medical College
Co-Director, Comprehensive Alzheimer’s Center
Vickie & Jack Farber Institute for Neuroscience
Thomas Jefferson University
Philadelphia, PA

Juan Fortea, MD, PhD

Professor of Neurology
Director, Alzheimer-Down Unit
Hospital de la Santa Creu i Sant Pau
Sant Pau Biomedical Research Institute
Barcelona, Spain

Ana M. Franceschi, MD, PhD

Associate Professor of Radiology
Director of Dementia Imaging
Director of Molecular Neuroimaging
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Lenox Hill Hospital
New York, New York

Giovanni B. Frisoni, MD

Professor of Clinical Neuroscience
University of Geneva
Director, Memory Clinic
Geneva University Hospitals
Geneva, Switzerland

Samuel Gandy, MD. PhD

Professor of Neurology & Psychiatry
Icahn School of Medicine at Mount Sinai
James J Peters VA Medical Center
New York, New York

James E. Galvin, MD, MPH

Professor of Neurology
University of Miami Miller School of Medicine
Miami, FL

David S. Geldmacher, MD

Professor and Director
Division of Memory Disorders and Behavioral Neurology
Department of Neurology
Heersink School of Medicine
University of Alabama at Birmingham
Birmingham, AL

George T. Grossberg, MD

Henry & Amelia Nasrallah Endowed Professor
Director of Geriatric Psychiatry
Department of Psychiatry & Behavioral Neuroscience
Saint Louis University School of Medicine
St. Louis, MO

M. Atsushi Iwata, MD, PhD

Professor of Neurology
Department of Neurology
The University of Tokyo
Tokyo, Japan

Scott A. Kaiser, MD

Director of Geriatric Cognitive Health
Pacific Neuroscience Institute
Santa Monica, CA
Adjunct Professor
USC Leonard Davis School of Gerontology
Los Angeles, CA

Lynn E. Kassel, PharmD, BCPS

Associate Professor of Pharmacy Practice
Drake University College of Pharmacy & Health Sciences
Des Moines, IA

Diana R. Kerwin, MD, CPI

President, Kerwin Medical Center
Chief, Geriatric Medicine, Texas Health Presbyterian Hospital
Dallas, TX

Alka Khera, MD

Assistant Professor
UT Southwestern Neurology
Dallas, TX

Sumeet Kumar, MBBS, DNB, FRCR, EDiNR

Senior Consultant, Department of Neuroradiology
National Neuroscience Institute of Singapore
Clinical Assistant Professor, Duke-NUS Medical School
Adjunct Director for Advanced Magnetic Resonance Imaging Research
Radiological Sciences Academic Clinical Program (RADSC ACP)
SingHealth Duke-NUS Academic Medical Centre
Singapore

Rosemary D. Laird, MD, MHSA, AGSF

Chief Medical Officer, My Memory Clinic
Principal Investigator, ClinCloud Clinical Trials
Viera, Florida

Chi-Ying (Roy) Lin, MD, MPH, FAAN

Director, CurePSP Center of Care for PSP, CBD, and MSA
Assistant Professor of Neurology
Alzheimer's and Parkinson's Disease Centers
Baylor College of Medicine
Houston, TX

Catherine A. Madison, MD

Founding Director Ray Dolby Brain Health Center
San Francisco, CA

Scott McGinnis, MD

Assistant Professor of Neurology, Harvard Medical School
Center for Alzheimer Research and Treatment
Brigham and Women's Hospital
Frontotemporal Disorders Unit
Massachusetts General Hospital
Boston, MA

Kristin S. Meyer, PharmD, BCGP, FASCP

Professor of Pharmacy Practice
Drake University College of Pharmacy and Health Sciences
Des Moines, IA

Charles Montano, MD

Owner, Principal Investigator
CT Clinical Research
Cromwell, CT

Mary Norman, MD

Geriatrician
Cedars-Sinai Medical Group
Los Angeles, CA

Tiago Gil Oliveira, MD, PhD

Associate Professor
Life and Health Sciences Research Institute
School of Medicine
University of Minho
Neuroradiologist
Hospital de Braga
Braga, Portugal

Monica Parker, MD

Associate Professor of Neurology
Lead, Outreach, Recruitment, and Engagement Core
Goizueta Alzheimer's Disease Research Center
Goizueta Brain Health Institute
Emory University
Atlanta, Georgia

Lucilla Parnetti, MD

Professor of Neurology
Department of Medicine and Surgery
University of Perugia
Perugia, Italy

Manisha Parulekar, MD, FACP, AGSF, CMD

Director, Division of Geriatrics
Co-director, Center for Memory Loss and Brain Health
Hackensack University Medical Center
Hackensack, NJ

Giulio Maria Pasinetti, MD, PhD

The Saunders Family Chair in Neurology, Professor in Neurology
Director, Mount Sinai Center in Advance Botanical Research in Molecular Integrative Neuroresilience
Icahn School of Medicine at Mount Sinai
New York, NY
Director, Basic and Biomedical Research and Training Program, Geriatric Research and Clinical Center
James J. Peters Department of Veterans Affairs Medical Center
Bronx, NY

Robert Perneczky, MD, PhD 

Professor of Psychiatry
Department of Psychiatry and Psychotherapy
Ludwig-Maximilians-University Munich
German Center for Neurodegenerative Diseases
Munich, Germany

Anton P. Porsteinsson, MD

William B. and Sheila Konar Professor of Psychiatry, Neurology,
Neuroscience, and Medicine
Director, Alzheimer’s Disease Care, Research and Education
Program (AD CARE)
University of Rochester School of Medicine and Dentistry
Rochester, NY

Michael S. Rafii, MD, PhD

Professor of Clinical Neurology
Medical Director, Alzheimer’s Therapeutic Research Institute
Keck School of Medicine of USC
Los Angeles, California, USA

William D. Rhoades, DO, FACP

Chief Medical Officer
Advocate Good Samaritan Hospital
Downers Grove, IL

Barry W. Rovner, MD

Professor, Departments of Psychiatry & Neurology
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA

Marwan Noel Sabbagh, MD, FAAN, FANA

Moreno Family Chair for Alzheimer’s Research
Vice Chairman for Research and Professor
Department of Neurology
Barrow Neurological Institute
Phoenix, AZ

Martin J. Sadowski, MD, PhD

Zachary and Elizabeth M. Fisher Professor of Neurodegeneration and Alzheimer's Disease
Professor of Neurology, Psychiatry, and Biochemistry & Molecular Pharmacology
New York University Grossman School of Medicine Director, Fisher Center Alzheimer’s Clinical Trials Program
New York, NY

Stephen Salloway, MD, MS

Professor, Psychiatry and Human Behavior
Professor of Neurology, Alpert Medical School of Brown University
Providence, Rhode Island

Angela Sanford, MD, CMD

Associate Professor of Internal Medicine-Geriatrics
Saint Louis University School of Medicine
Ballwin, MO

Philip Scheltens, MD, PhD

Professor Emeritus of Neurology
Amsterdam University Medical Center
Head Dementia Fund at EQT Life Sciences
Amsterdam, Netherlands

Suzanne E. Schindler, MD, PhD

Associate Professor of Neurology
Division of Neurology
Washington University School of Medicine in St. Louis
Investigator, Knight Alzheimer Disease Research Center
St. Louis, Missouri, USA

Paul E. Schulz, MD

Rick McCord Professor of Neurology
Umphrey Family Professor of Neurodegenerative Disorders
Director, Memory Disorders and Dementia Clinic
UTHealth Houston
Houston, TX

Sharon J. Sha, MD, MS

Clinical Professor
Clinical Professor Neurology and Neurological Sciences Stanford University Chief, Stanford Memory Disorders Center Stanford Medicine Health Care
Palo Alto, CA

Jiong Shi, MD

Professor of Neurology
Department of Neurology
Huashan Hospital
Fudan University
Shanghai, China

Neil Skolnik, MD

Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA

Sandra Swantek, MD

Director, Section of Geriatric Psychiatry
RUSH University Medical Center
Chicago, IL

R. Scott Turner, PhD, MD

Professor of Neurology
Director of the Memory Disorders Program
Georgetown University
Washington, DC

Lawren VandeVrede, MD, PhD

Assistant Professor of Neurology
Memory and Aging Center
Department of Neurology
University of California, San Francisco
San Francisco, California, USA

Chuck Vega, MD, FAAFP

Health Sciences Clinical Professor
UC Irvine Department of Family Medicine
Director, UCI Program in Medical Education for the Latino Community
University of California Irvine
Irvine, CA

Nicolas Villain, MD, PhD

Professor of Neurology
Department of Neurology
Sorbonne University
Neurologist, Pitié-Salpêtrière Hospital
Assistance Publique – Hôpitaux de Paris
Paris, France

Geoffrey C. Wall, PharmD, FCCP, BCPS

John R. Ellis Distinguished Chair of Pharmacy Practice
Professor of Clinical Sciences
Director, Drake Drug Information Center
Drake University College of Pharmacy and Health Sciences
Internal Medicine Clinical Pharmacist
Iowa Methodist Medical Center
Des Moines, IA

David A. Wolk, MD, FAAN

Professor of Neurology
Director, Penn Alzheimer’s Disease Research Center
University of Pennsylvania
Philadelphia, PA

  • Clinicians

The Burden of AD

Diagnosis and Assessing AD

Treating and Managing Alzheimer's

AD Rapid Referral

Clinical Exchange

Additional Resources

  • Caregivers & Patients

What is Alzheimer's?

Treating Alzheimer's

Living with Alzheimer's

Resources and Alzheimer’s Network

FAQ's